Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75550.42 1090.89 (1.47%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
31	Suraksha Diagnostic Ltd.	Q V PT	1,653 Small Cap	325 (2.39%)	46.18	6.44	17.26	-44.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,906 Small Cap	1,438.55 (-0.60%)	79.51	14.8	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Neuland Laboratories Ltd.	Q V+ PT	25,276 Small Cap	19,550.15 (-0.77%)	50.78	12.51	16.64	37.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Marksans Pharma Ltd.	Q V+ PT	13,896 Small Cap	310 (1.09%)	26.89	4.37	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Windlas Biotech Ltd.	Q V PT	1,810 Small Cap	867.15 (-1.15%)	27.24	3.52	16.15	12.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Caplin Point Laboratories Ltd.	Q V PT	17,672 Small Cap	2,342.70 (0.77%)	26.56	4.81	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,20,779 Large Cap	8,430.30 (0.36%)	76.88	11.71	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Natco Pharma Ltd.	Q V+ PT	15,350 Small Cap	784.75 (0.29%)	13.41	1.45	14.72	28.08	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Vimta Labs Ltd.	Q V+ PT	2,167 Small Cap	488.30 (0.71%)	26.97	4.41	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	GPT Healthcare Ltd.	Q V PT	1,089 Small Cap	133.30 (0.45%)	23.04	3.86	14.25	6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	NGL Fine-Chem Ltd.	Q V PT	1,576 Small Cap	2,557.20 (0.24%)	27.55	4.53	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Anthem Biosciences Ltd.	Q V PT	46,685 Mid Cap	834.05 (0.68%)	81.06	14.92	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,604 Small Cap	3,511.15 (1.08%)	44.47	10.11	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Blue Jet Healthcare Ltd.	Q V PT	9,547 Small Cap	501.20 (-0.63%)	40.64	4.27	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Ajanta Pharma Ltd.	Q V+ PT	43,891 Mid Cap	3,425.80 (-2.47%)	34.76	9.03	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Zydus Lifesciences Ltd.	Q V PT	1,24,089 Mid Cap	1,239.05 (-0.40%)	27.5	4.6	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Gland Pharma Ltd.	Q V PT	51,112 Mid Cap	3,069 (-0.92%)	45.28	4.81	13.18	0.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Lupin Ltd.	Q V PT	91,870 Mid Cap	2,027.70 (0.93%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Unichem Laboratories Ltd.	Q V PT	3,404 Small Cap	494 (2.18%)	11.17	1.24	12.26	24.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Dr. Lal Pathlabs Ltd.	Q V PT	31,997 Small Cap	1,874 (-1.69%)	58.73	12.44	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Dr. Reddys Laboratories Ltd.	Q V PT	1,12,699 Mid Cap	1,356.70 (0.48%)	40.25	2.9	12.09	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	Medicamen Biotech Ltd.	Q V+ PT	359 Small Cap	256.85 (0.53%)	33.18	1.26	11.90	-6.38	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,76,306 Large Cap	4,597.90 (-0.80%)	83.01	9.6	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Sun Pharmaceutical Industries Ltd.	Q V PT	4,26,662 Large Cap	1,769.30 (-0.50%)	38.91	4.78	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Concord Biotech Ltd.	Q V PT	13,028 Small Cap	1,188 (-4.60%)	46.12	6.28	11.33	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	Shilpa Medicare Ltd.	Q V+ PT	18,671 Small Cap	945.90 (-0.92%)	62.8	6.95	11.30	12.66	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Thyrocare Technologies Ltd.	Q V PT	7,274 Small Cap	465.50 (1.86%)	50.44	13.14	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Alkem Laboratories Ltd.	Q V PT	61,277 Mid Cap	5,089.40 (-0.69%)	28.4	4.28	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Metropolis Healthcare Ltd.	Q V PT	11,310 Small Cap	551.10 (1.09%)	56.09	7.25	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Wanbury Ltd.	Q V+ PT	664 Small Cap	190.10 (0.18%)	15.44	9.89	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,840.30	7.01%
Advanced Enzyme Tech	279.60	6.33%
Indegene	622.10	5.86%
Themis Medicare	99.84	5.09%
Max Healthcare Inst.	900	4.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	25.02	-5.23%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,188	-4.60%
Bliss GVS Pharma	623	-3.92%
Artemis MedicareServ	281.55	-3.64%

News about Top Pharma Companies in India

Oct, 2026

Vimta Labs - Quaterly Results

A fair growth of 9.95% in the revenue at Rs. 1119.83 millions was reported in the September 2026 quarter as compared to Rs. 1018.48 millions during year-ago period.A meek growth of 3.48% was reported for the quarter ended September 2026 to Rs. 206.14 millions from Rs. 199.20 millions.Operating profit surged to 407.78 millions from the corresponding previous quarter of 368.88 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	1119.83	1018.48	9.95	2210.57	1994.12	10.85	4072.90	3439.82	18.40
Other Income	29.04	26.58	9.26	67.16	44.07	52.39	89.89	42.40	112.00
PBIDT	407.78	368.88	10.55	819.01	723.27	13.24	1505.08	1261.89	19.27
Interest	3.85	3.74	2.94	6.22	6.89	-9.72	11.67	19.00	-38.58
PBDT	403.93	365.14	10.62	812.79	716.38	13.46	1477.25	1242.89	18.86
Depreciation	128.68	102.40	25.66	254.16	201.02	26.44	437.72	352.89	24.04
PBT	275.25	262.74	4.76	558.63	515.36	8.40	1039.53	890.00	16.80
TAX	69.11	63.54	8.77	142.07	127.22	11.67	264.41	222.45	18.86
Deferred Tax	1.58	-3.17	-149.84	16.02	-7.23	-321.58	-1.07	12.66	-108.45
PAT	206.14	199.20	3.48	416.56	388.14	7.32	775.12	667.55	16.11
Equity	89.40	89.08	0.36	89.40	89.08	0.36	89.34	44.47	100.90
PBIDTM(%)	36.41	36.22	0.54	37.05	36.27	2.15	36.95	36.68	0.73

Oct, 2026

Sun Pharma. Inds. - Quaterly Results

The sales surged to Rs. 61419.20 millions, up 35.04% for the September 2026 quarter as against Rs. 45481.10 millions during the corresponding quarter previous year.Profit after tax for the quarter ended September 2026 reported a huge growth of 54.42% to Rs. 8712.90 millions from Rs. 5642.20 millions.Operating Profit saw a handsome growth to 17957.40 millions from 12563.80 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	61419.20	45481.10	35.04	118830.50	101429.90	17.16	207546.40	229774.00	-9.67
Other Income	810.10	727.90	11.29	2211.80	1765.00	25.31	4193.30	3791.40	10.60
PBIDT	17957.40	12563.80	42.93	39001.20	32696.20	19.28	66000.20	72168.40	-8.55
Interest	2769.60	2483.30	11.53	5554.40	4867.50	14.11	9478.40	9538.90	-0.63
PBDT	15187.80	10080.50	50.67	33131.50	24952.30	32.78	51058.40	62629.50	-18.48
Depreciation	3157.90	3363.00	-6.10	6237.10	6472.20	-3.63	13117.20	12867.40	1.94
PBT	12029.90	6717.50	79.08	26894.40	18480.10	45.53	37941.20	49762.10	-23.75
TAX	3317.00	1075.30	208.47	7030.10	5387.30	30.49	11707.00	7481.30	56.48
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	8712.90	5642.20	54.42	19864.30	13092.80	51.72	26234.20	42280.80	-37.95
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	29.24	27.62	5.84	32.82	32.24	1.82	31.80	31.41	1.25

Oct, 2026

Ajanta Pharma - Quaterly Results

The sales moved up 41.37% to Rs. 17250.70 millions for the September 2026 quarter as compared to Rs. 12202.40 millions during the year-ago period.Profit after tax for the quarter ended September 2026 reported a huge growth of 52.24% to Rs. 3798.90 millions from Rs. 2495.30 millions.Operating Profit saw a handsome growth to 5697.10 millions from 3646.20 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	17250.70	12202.40	41.37	32137.40	24288.00	32.32	48459.20	43220.40	12.12
Other Income	526.20	750.30	-29.87	1234.40	1156.60	6.73	2044.00	1198.70	70.52
PBIDT	5697.10	3646.20	56.25	10372.30	7346.50	41.19	14023.90	13245.90	5.87
Interest	7.90	7.30	8.22	15.50	14.60	6.16	25.90	46.00	-43.70
PBDT	5689.20	3638.90	56.34	10356.80	7331.90	41.26	13998.00	13199.90	6.05
Depreciation	463.00	419.20	10.45	896.10	822.30	8.97	1687.70	1399.30	20.61
PBT	5226.20	3219.70	62.32	9460.70	6509.60	45.33	12310.30	11800.60	4.32
TAX	1427.30	724.40	97.03	2507.10	1464.60	71.18	2842.10	2631.70	7.99
Deferred Tax	-158.10	64.70	-344.36	-94.60	97.60	-196.93	76.00	51.40	47.86
PAT	3798.90	2495.30	52.24	6953.60	5045.00	37.83	9468.20	9168.90	3.26
Equity	250.70	250.70	0.00	250.70	250.70	0.00	250.70	250.70	0.00
PBIDTM(%)	33.03	29.88	10.52	32.27	30.25	6.70	28.94	30.65	-5.57

Oct, 2026

Sun Pharma’s consolidated net profit falls 36% in Q2

The total consolidated income of the company has increased by 11.83% at Rs 16,716.03 crore for Q2FY27

Oct, 2026

Vimta Labs informs about unaudited financial results

Vimta Labs has enclosed unaudited Financial Results as per Regulation 33 of the SEBI (LODR) Regulations, 2015 for the 02nd Quarter and Half Year ended 30th September 2026 along with Limited Review Report. The said Financial Results were duly reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company, at their respective meetings held today. Further to earlier intimation dated 6th May 2026 regarding the proposed incorporation of a wholly owned subsidiary in the USA, the Board of Directors of the Company, at its meeting held today, took note of the incorporation of Vimta Labs LLC as a wholly owned subsidiary of the Company. The meeting of the Board of Directors of the Company commenced at 10:30 AM and concluded at 01:00 PM.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Wanbury zooms on securing GMP Compliance Certificate for Tanuku Plant from Australia's TGA

The certificate was issued on October 28, 2026 and is valid until December 9, 2028

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	RPG Life Sciences Ltd.	4,255 Crore
2	Manipal Health Enterprises Ltd.	87,926 Crore
3	Rubicon Research Ltd.	26,650 Crore
4	Yatharth Hospital & Trauma Care Services Ltd.	8,942 Crore
5	Dr. Agarwals Health Care Ltd.	16,117 Crore
6	Innova Captab Ltd.	5,900 Crore
7	Acutaas Chemicals Ltd.	32,770 Crore
8	Indegene Ltd.	14,164 Crore
9	Kilitch Drugs (India) Ltd.	703 Crore
10	Max Healthcare Institute Ltd.	83,706 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,598	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,380	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,668	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,966	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,239	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,357	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Vimta Labs - Quaterly Results

Sun Pharma. Inds. - Quaterly Results

Ajanta Pharma - Quaterly Results

Sun Pharma’s consolidated net profit falls 36% in Q2

Vimta Labs informs about unaudited financial results

Wanbury zooms on securing GMP Compliance Certificate for Tanuku Plant from Australia's TGA

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?